Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 2, 2006, Pages 765-769

  Kosowska Shick, Klaudia ^a   Clark, Catherine ^a   Credito, Kim ^a   McGhee, Pamela ^a   Dewasse, Bonifacio ^a   Bogdanovich, Tatiana ^a   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFALEXIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FUSIDIC ACID; LINEZOLID; PSEUDOMONIC ACID; RETAPAMULIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CLONE; MINIMUM INHIBITORY CONCENTRATION; MUTANT; MUTATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN SYNTHESIS INHIBITORS; RIBOSOMAL PROTEINS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 31944450793     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.2.765-769.2006     Document Type: Article

References (11)

1. Antonio, M., N. McFerran, and M. J. Pallen. 2002. Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 46:438-442.
2. Böck, A., F. Turnowsky, and G. Högenauer. 1982. Tiamulin resistance mutations in Escherichia coli. J. Bacterioi. 151:1253-1260.
3. Bogdanovich, T., L. M. Ednie, S. Shapiro, and P. C. Appelbaum. 2005. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob. Agents Chemother. 49:4210-4219.
4. Bozdogan, B., L. M. Ednie, K. Credito, K. Kosowska, and P. C. Appelbaum. 2004. Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center. Antimicrob. Agents Chemother. 12:4762-4765.
5. Hunt, E. 2000. Pleuromutilin antibiotics. Drugs Future 25:1163-1168.
6. Kosowska, K., D. B. Hoellman, G. Lin, C. Clark, K. Credito, P. McGhee, B. Dewasse, B. Bozdogan, S. Shapiro, and P. C. Appelbaum. 2005. Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin. Antimicrob. Agents Chemother. 49:1932-1942.
7. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. O'Neill, A. J., A. R. Larsen, A. S. Henriksen, and I. A. Chopra. 2004. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. Antimicrob. Agents Chemother. 48:3594-3597.
9. Pringle, M., J. Poehlsgaard, B. Vester, and K. S. Long. 2004. Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates. Mol. Microbiol. 54:1295-1306.
10. Prunier, A. L., H. N. Trong, D. Tande, C. Segond, and R. Leclercq. 2005. Mutation of L4 ribosomal protein conferring unusual macrolide resistance in two independent clinical isolates of Staphylococcus aureus. Microb. Drug Resist. 11:18-20.
11. Tait-Kamradt, A., T. Davies, P. C. Appelbaum, F. Depardieu, P. Courvalin, J. Petitpas, L. Wondrack, A. Walker, M. R. Jacobs, and J. Sutcliffe. 2000. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 44:3395-3401.